Concepedia

Emily J. Faivre

EJ

Statistics

Publications

20

Citations

3K

H-Index

18

Active since

2003

Affiliations

AbbVie (United States)(Current)

Masonic Cancer Center

University of Minnesota Medical Center

University of California, San Francisco

Minnesota Oncology

Emily J. Faivre is an author at AbbVie (United States) specializing in life sciences, cell signaling, and molecular biology.

Publications per year

2003–2021

20

Publications

20

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 858 citations · Full text

, , +8

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 404 citations

, , +10

Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells

Emily J. Faivre, Carol A. Lange · Molecular and Cellular Biology · 2006 · 212 citations · Full text

, , +17

Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors

Emily J. Faivre, Andrea R. Daniel, Christopher Hillard et al. · Molecular Endocrinology · 2008 · 154 citations · Full text

, , +17

Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases

Andrew Skildum, Emily J. Faivre, Carol A. Lange · Molecular Endocrinology · 2004 · 152 citations

, , +17

1–5 of 20